Effect of Ca2+ channel blockers on arterial hypertension and heart ischaemic lesions induced by chronic blockade of nitric oxide in the rat

European Journal of Pharmacology

Volumn 373, Issue 2-3, 1999, Pages 195-200

  De Oliveira, Cláudia F ^a   Nathan, Luciana P ^a   Metze, Konradin ^a   Moreno Jr , Heitor ^a   De Luca, Iara M S ^a   Sucupira, Mauro ^b   Zatz, Roberto ^b   Zappellini, Aldete ^a   Antunes, Edson ^a   De Nucci, Gilberto ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amlodipine; Diltiazem; Heart ischaemic lesion; Hypertension; Nifedipine

Indexed keywords

AMLODIPINE; ARGININE METHYL ESTER; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; NIFEDIPINE; NITRIC OXIDE; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG BLOOD LEVEL; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HYPERTENSION; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DRUG EFFECT; HEART VENTRICLE; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; SURVIVAL; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; ENZYME INHIBITORS; HEART VENTRICLES; HYPERTENSION; MALE; MYOCARDIAL ISCHEMIA; NG-NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE; RATS; RATS, WISTAR; SURVIVAL ANALYSIS;

EID: 0032588464     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00267-8     Document Type: Article

References (22)

1. Aherne W. Quantitative methods in histology. J. Med. Lab. Technol. 27:1970;160-170.
2. Amrani M., O'Shea J., Allen N.J., Harding S.E., Jayakumar J., Pepper J.R., Moncada S. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J. Physiol. 456:1992;681-687.
3. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90:1992;278-281.
4. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator appears abnormal. J. Hypertens. 10:1992;1025-1031.
5. Cookcroft J.R., Chowienczyk P.J., Benjamin N., Ritter J.M. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N. Engl. J. Med. 330:1994;1036-1040.
6. Furberg C.D., Psaty M.B., Meyer J.V. Nifedipine-dose-related increase in mortality in patients with coronary heart disease. Circulation. 92:1995;1326-1331.
7. Hirooka Y., Imaizumi T., Masaki H., Ando S., Harada S., Momohara N., Takeshita A. Captopril improves impaired endothelium-dependent vasodilatation in hypertensive patients. Hypertension. 20:1992;175-180.
8. Huckstorf C., Zanzinger J., Fink B., Bassenge E. Reduced nitric oxide formation causes coronary vasoconstriction and impaired dilator responses to endogenous agonists and hypoxia in dogs. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:1994;367-373.
9. G-nitro-arginine. Br. J. Pharmacol. 102:1991;565-566.
10. Mackay J.A., Sever P.S. Calcium channel blockers in the dock: innocent or guilty? J. Hum. Hypertens. 10:1996;277-280.
11. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012.
12. Moreno H. Jr., Nathan L.P., Costa S.K.P., Metze K., Antunes E., Zatz R., de Nucci G. Enalapril does not prevent the myocardial ischaemia caused by the chronic inhibition of nitric oxide synthesis. Eur. J. Pharmacol. 287:1995;93-96.
13. Moreno H. Jr., Metze K., Bento A.C., Antunes E., Zatz R., de Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res. Cardiol. 91:1996;248-255.
14. Moreno H. Jr., Nathan L.P., Metze K., Costa S.K.P., Antunes E., Hyslop S., Zatz R., de Nucci G. Non-specific inhibitors of nitric oxide synthase cause myocardial necrosis in the rat. Clin. Exp. Pharmacol. Physiol. 24:1997;349-352.
15. Natsume T., Gallo A.J., Pegram B.L., Frohlich E.D. Hemodynamic effects of prolonged treatment with diltiazem in conscious normotensive and spontaneously hypertensive rats. Clin. Exp. Hypertens. 7:1985;1471-1479.
16. Pahor M., Guralnik J.M., Corti M.C., Foley D.J., Carbonin P., Havlik R.J. Long-term survival and use of antihypertensive medications in older persons. J. Am. Geriatr. Soc. 43:1995;1191-1197.
17. Psaty B.M., Heckbert S.R., Koepsell T.D., Siscovick D.S., Raghunathan T.E., Weiss N.S., Rosendaal F.R., Lemaitre R.N., Smith N.L., Wahl P.W., Wagner E.H., Furberg C.D. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 274:1995;620-625.
18. Ribeiro M.O., Antunes E., de Nucci G., Lovisolo S.M., Zatz R. Chronic inhibition of nitric oxide synthesis - a new model of arterial hypertension. Hypertension. 20:1992;298-303.
19. Ribeiro M.O., Antunes E., Muscará M.N., de Nucci G., Zatz R. Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition. Hypertension. 26:1995;150-155.
20. Takase H., Moreau P., Küng C.F., Nava E., Lüscher T.F. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency - effect of verapamil and trandolapril. Hypertension. 27:1996;25-31.
21. Takemoto M., Egashira K., Usui M., Numaguchi K., Tomita H., Tsutsui H., Shimokawa H., Sulish K., Takeshita A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J. Clin. Invest. 99:1997;278-287.
22. Zatz R. A low cost tail-cuff method for the estimation of mean arterial pressure in conscious rats. Lab. Anim. Sci. 40:1990;198-201.